Advanced search×

Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus.

Br J Dermatol 163(1):83-92 (2010) PMID 20394621

In 2005, a scoring system (CLASI, Cutaneous Lupus Erythematosus Disease Area and Severity Index) was developed for patients with cutaneous lupus erythematosus (CLE) to assess disease 'activity' and 'damage'. However, the CLASI does not give an accurate assessment of the severity in all disease subtypes.

DOI: 10.1111/j.1365-2133.2010.09799.x
Version: za2963e q8zae q8zb1 q8zcb q8zd8 q8ze9 q8zf4 q8zgf

Similar articles you may find interesting…

  1. n-3 fatty acids in patients with multiple cardiovascular risk factors.

    N Engl J Med 368(19):1800-8 (2013) PMID 23656645

    We evaluated the potential benefit of such therapy in patients with multiple cardiovascular risk factors or atherosclerotic vascular disease who had not had a myocardial infarction. In this double-blind, placebo-controlled clinical trial, we enrolled a cohort of patients who were fol...
  2. Epidemiology of Obstetric-Related ICU Admissions in Maryland: 1999-2008.

    Crit Care Med (2013) PMID 23648568

    : Between 1999 and 2008, 419.1 per 100,000 deliveries in Maryland were complicated by ICU admission. Hospitals providing obstetric services should plan for appropriate critical care management and/or transfer of women with severe morbidities during pregnancy....
  3. Pediatric lupus nephritis: more options, more chances?

    Lupus (2013) PMID 23629826

    Lupus nephritis (LN) is more common and severe in childhood-onset systemic lupus erythematosus (SLE) than in adults. It is one of the major causes of acute kidney injury (AKI) and chronic kidney disease (CKD) in children. Steroid therapy has been used as the first-line treatment for...